It is inferred that neoantigens produced by NF2/YAP mutated cancer cells can be identified by serological analysis techniques of recombinant expression cDNA clones, total exon sequencing (WES) combined with RNA sequencing (RNA-seq) and epitope prediction methods, and LC-MS/MS methods. The gene discussed is YAP1; the disease is cancer.